Postmarketing Safety Surveillance of a Hexavalent Vaccine in the Vaccine Adverse Event Reporting System.
J Pediatr
; 262: 113643, 2023 11.
Article
in En
| MEDLINE
| ID: mdl-37517652
ABSTRACT
We assessed the safety of hexavalent vaccine diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, hepatitis b, and haemophilus influenzae b conjugate vaccine in the Vaccine Adverse Event Reporting System. Five hundred-one reports of adverse events (AEs) were identified; 21 (4.2%) were serious. Most frequently reported AEs were fever (10.2%) and injection site erythema (5.4%). AEs reported were consistent with findings from prelicensure studies.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diphtheria-Tetanus-Pertussis Vaccine
/
Haemophilus Vaccines
Type of study:
Prognostic_studies
/
Screening_studies
Limits:
Humans
Language:
En
Journal:
J Pediatr
Year:
2023
Document type:
Article